Rodman & Renshaw has recently initiated CorMedix Inc (CRMD) stock to Buy rating, as announced on August 26, 2024, according to Finviz. Earlier, on August 10, 2023, RBC Capital Mkts had initiated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback